TGFBR2 and colorectal cancer: More than 90% of MSI colorectal cancers have acquired somatic insertion/deletion mutations in the coding mononucleotide repeat (A10) in exon 3 of the Transforming growth factor beta receptor type 2 (TGFBR2) gene leading to translational frameshifts and impaired receptor signaling [5, 6].